Cargando…
The effects of tirofiban infusion on clinical and angiographic outcomes of patients with STEMI undergoing primary PCI
OBJECTIVE: The present study was designed to determine the effects of tirofiban (Tiro) infusion on angiographic measures, ST-segment resolution, and clinical outcomes in patients with STEMI undergoing PCI. Glycoprotein (GP) IIb/IIIa inhibitors are beneficial in ST-segment elevation myocardial infarc...
Autores principales: | Kaymaz, Cihangir, Keleş, Nurşen, Özdemir, Nihal, Tanboğa, İbrahim Halil, Demircan, Hacer C., Can, Mehmet M., Koca, Fatih, İzgi, İbrahim Akın, Özkan, Alper, Türkmen, Muhsin, Kırma, Cevat, Esen, Ali M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kare Publishing
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5336940/ https://www.ncbi.nlm.nih.gov/pubmed/25868037 http://dx.doi.org/10.5152/akd.2014.5656 |
Ejemplares similares
-
Role of tirofiban with dual antiplatelet therapy in patients with STEMI undergoing primary PCI
por: Türker, Yasin
Publicado: (2016) -
Closure of mitral paravalvular defects without performing an arteriovenous loop: a case series of fourteen patients
por: Kilicgedik, Alev, et al.
Publicado: (2017) -
High Bolus Tirofiban vs Abciximab in Acute STEMI Patients Undergoing Primary PCI – The Tamip Study
por: Balghith, Mohammed A.
Publicado: (2012) -
Apical systolic flow within the left ventricle: A novel and simple Doppler parameter in prediction of mitral regurgitation severity
por: Tokgöz, Hacer Ceren, et al.
Publicado: (2015) -
Reply to Letter to the Editor: “Single-Stent Double-Kissing Nano-Crush Technique for the Management of Side Branch Ostial Lesions: A Game Changer? Or Just Another Player in the Game?”
por: Acar, Emrah, et al.
Publicado: (2023)